Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease

M Lemaitre, J Kirchgesner, A Rudnichi, F Carrat… - Jama, 2017 - jamanetwork.com
Importance An increased risk of lymphoma has been reported among patients receiving
thiopurines for inflammatory bowel disease (IBD). The risk of lymphoma associated with anti …
被引用次数：520 相关文章
[HTML] nih.gov

[HTML][HTML] Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory …

M Lemaitre, J Kirchgesner, A Rudnichi, F Carrat… - JAMA, 2017 - ncbi.nlm.nih.gov
Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in
Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease - PMC …

[引用][C] Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory …

M Lemaitre, J Kirchgesner, A Rudnichi… - Journal of the American …, 2017 - hal.science
Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in
Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease - Archive …

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel …

M Lemaitre, J Kirchgesner, A Rudnichi, F Carrat… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Importance An increased risk of lymphoma has been reported among patients receiving
thiopurines for inflammatory bowel disease (IBD). The risk of lymphoma associated with anti …

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel …

M Lemaitre, J Kirchgesner, A Rudnichi, F Carrat… - JAMA, 2017 - europepmc.org
Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in
Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease …

[引用][C] Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory …

M Lemaitre, J Kirchgesner… - Journal of the …, 2017 - hal.sorbonne-universite.fr
Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in
Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease - Sorbonne …

[引用][C] Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory …

M Lemaitre, J Kirchgesner, A Rudnichi, F Carrat… - JAMA, 2017 - cir.nii.ac.jp
Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in
Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease | CiNii …

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel …

M Lemaitre, J Kirchgesner, A Rudnichi, F Carrat… - JAMA, 2017 - europepmc.org
Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in
Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease. - Abstract …